| Votrient (pazopanib) now available for the treatment of advanced renal cell ... - Pharmacy Europe |
|
|
Pharmacy EuropeGlaxoSmithKline (GSK) announced today that Votrient (pazopanib) is now available for the first-line treatment of patients with advanced renal cell carcinoma ...Votrient®? (pazopanib) now available for the treatment of advanced renal cell ... read more |